Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Enrichment of cancer stem-like cells by the induction of epithelial-mesenchymal transition using lentiviral vector carrying E-cadherin shRNA in HT29 cell line.

Saltanatpour Z, Johari B, Alizadeh A, Lotfinia M, Majidzadeh-A K, Nikbin B, Kadivar M.

J Cell Physiol. 2019 May 20. doi: 10.1002/jcp.28855. [Epub ahead of print]

PMID:
31111504
2.

The Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer Prior to any Systematic Therapy: A Systematic Review.

Mansouri S, Hesari PM, Naghavi-Al-Hosseini F, Majidzadeh-A K, Farahmand L.

Curr Stem Cell Res Ther. 2019 Mar 5. doi: 10.2174/1574888X14666190306103759. [Epub ahead of print]

PMID:
30843493
3.

Sandwich-structured nanoparticles-grafted functionalized graphene based 3D nanocomposites for high-performance biosensors to detect ascorbic acid biomolecule.

Salahandish R, Ghaffarinejad A, Naghib SM, Niyazi A, Majidzadeh-A K, Janmaleki M, Sanati-Nezhad A.

Sci Rep. 2019 Feb 4;9(1):1226. doi: 10.1038/s41598-018-37573-9.

4.

Challenges facing antiangiogenesis therapy: The significant role of hypoxia-inducible factor and MET in development of resistance to anti-vascular endothelial growth factor-targeted therapies.

Mahdi A, Darvishi B, Majidzadeh-A K, Salehi M, Farahmand L.

J Cell Physiol. 2019 May;234(5):5655-5663. doi: 10.1002/jcp.27414. Epub 2018 Dec 4. Review.

PMID:
30515806
5.

Recruited bone marrow derived cells, local stromal cells and IL-17 at the front line of resistance development to anti-VEGF targeted therapies.

Darvishi B, Majidzadeh-A K, Ghadirian R, Mosayebzadeh M, Farahmand L.

Life Sci. 2019 Jan 15;217:34-40. doi: 10.1016/j.lfs.2018.11.033. Epub 2018 Nov 22. Review.

PMID:
30472294
6.

The antiproliferative effects of cold atmospheric plasma-activated media on different cancer cell lines, the implication of ozone as a possible underlying mechanism.

Mokhtari H, Farahmand L, Yaserian K, Jalili N, Majidzadeh-A K.

J Cell Physiol. 2019 May;234(5):6778-6782. doi: 10.1002/jcp.27428. Epub 2018 Nov 1.

PMID:
30387137
7.

Self-filling microwell arrays (SFMAs) for tumor spheroid formation.

Seyfoori A, Samiei E, Jalili N, Godau B, Rahmanian M, Farahmand L, Majidzadeh-A K, Akbari M.

Lab Chip. 2018 Nov 6;18(22):3516-3528. doi: 10.1039/c8lc00708j.

PMID:
30357219
8.

Chondrosarcoma: An overview of clinical behavior, molecular mechanisms mediated drug resistance and potential therapeutic targets.

Nazeri E, Gouran Savadkoohi M, Majidzadeh-A K, Esmaeili R.

Crit Rev Oncol Hematol. 2018 Nov;131:102-109. doi: 10.1016/j.critrevonc.2018.09.001. Epub 2018 Sep 12. Review.

PMID:
30293700
9.

A Review on The Role of VEGF in Tamoxifen Resistance.

Mansouri S, Feizi N, Mahdi A, Majidzadeh-A K, Farahmand L.

Anticancer Agents Med Chem. 2018;18(14):2006-2009. doi: 10.2174/1871520618666180911142259.

PMID:
30207246
10.

Label-free ultrasensitive detection of breast cancer miRNA-21 biomarker employing electrochemical nano-genosensor based on sandwiched AgNPs in PANI and N-doped graphene.

Salahandish R, Ghaffarinejad A, Omidinia E, Zargartalebi H, Majidzadeh-A K, Naghib SM, Sanati-Nezhad A.

Biosens Bioelectron. 2018 Nov 30;120:129-136. doi: 10.1016/j.bios.2018.08.025. Epub 2018 Aug 11.

PMID:
30172235
11.

Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety.

Ayati A, Oghabi Bakhshaiesh T, Moghimi S, Esmaeili R, Majidzadeh-A K, Safavi M, Firoozpour L, Emami S, Foroumadi A.

Eur J Med Chem. 2018 Jul 15;155:483-491. doi: 10.1016/j.ejmech.2018.06.015. Epub 2018 Jun 7.

PMID:
29908441
12.

Nano-biosensor for highly sensitive detection of HER2 positive breast cancer.

Salahandish R, Ghaffarinejad A, Naghib SM, Majidzadeh-A K, Zargartalebi H, Sanati-Nezhad A.

Biosens Bioelectron. 2018 Oct 15;117:104-111. doi: 10.1016/j.bios.2018.05.043. Epub 2018 May 25.

PMID:
29890392
13.

The effect of mesenchymal stem cell-conditioned medium on proliferation and apoptosis of breast cancer cell line.

Farahmand L, Esmaeili R, Eini L, Majidzadeh-A K.

J Cancer Res Ther. 2018 Jan-Mar;14(2):341-344. doi: 10.4103/0973-1482.177213.

14.

Stemness Phenotype in Tamoxifen Resistant Breast Cancer Cells May be Induced by Interactions Between Receptor Tyrosine Kinases and ERα-66.

Farahmand L, Mansouri S, Jafarbeik-Iravani N, Teymourzadeh A, Majidzadeh-A K.

Recent Pat Anticancer Drug Discov. 2018;13(3):302-307. doi: 10.2174/1574892813666180305164634. Review.

PMID:
29512469
15.

Exosomes in Cancer Liquid Biopsy: A Focus on Breast Cancer.

Halvaei S, Daryani S, Eslami-S Z, Samadi T, Jafarbeik-Iravani N, Bakhshayesh TO, Majidzadeh-A K, Esmaeili R.

Mol Ther Nucleic Acids. 2018 Mar 2;10:131-141. doi: 10.1016/j.omtn.2017.11.014. Epub 2017 Dec 1. Review.

16.

Unique CD44 intronic SNP is associated with tumor grade in breast cancer: a case control study and in silico analysis.

Esmaeili R, Abdoli N, Yadegari F, Neishaboury M, Farahmand L, Kaviani A, Majidzadeh-A K.

Cancer Cell Int. 2018 Feb 23;18:28. doi: 10.1186/s12935-018-0522-2. eCollection 2018.

17.

Synthesis and biological evaluation of 4-amino-5-cinnamoylthiazoles as chalcone-like anticancer agents.

Ayati A, Esmaeili R, Moghimi S, Oghabi Bakhshaiesh T, Eslami-S Z, Majidzadeh-A K, Safavi M, Emami S, Foroumadi A.

Eur J Med Chem. 2018 Feb 10;145:404-412. doi: 10.1016/j.ejmech.2018.01.015. Epub 2018 Jan 6.

PMID:
29335206
18.

Study of the tumor microenvironment during breast cancer progression.

Eftekhari R, Esmaeili R, Mirzaei R, Bidad K, de Lima S, Ajami M, Shirzad H, Hadjati J, Majidzadeh-A K.

Cancer Cell Int. 2017 Dec 22;17:123. doi: 10.1186/s12935-017-0492-9. eCollection 2017.

19.

Metas-Chip precisely identifies presence of micrometastasis in live biopsy samples by label free approach.

Nikshoar MS, Khayamian MA, Ansaryan S, Sanati H, Gharooni M, Farahmand L, Rezakhanloo F, Majidzadeh-A K, Hoseinpour P, Dadgari S, Kiani-M L, Saqafi M, Gity M, Abdolahad M.

Nat Commun. 2017 Dec 19;8(1):2175. doi: 10.1038/s41467-017-02184-x.

20.

Functionalised nanomaterials for eradication of CSCs, a promising approach for overcoming tumour heterogeneity.

Farahmand L, Darvishi B, Salehi M, Samadi Kouchaksaraei S, Majidzadeh-A K.

J Drug Target. 2018 Sep;26(8):649-657. doi: 10.1080/1061186X.2017.1405426. Epub 2017 Nov 23.

PMID:
29169275
21.

Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor κB transcription factor decoy oligodeoxynucleotides.

Farahmand L, Darvishi B, Majidzadeh-A K.

Drug Deliv. 2017 Nov;24(1):1249-1261. doi: 10.1080/10717544.2017.1370511. Review.

PMID:
28870118
22.

Active Expression of Human Tissue Plasminogen Activator (t-PA) c-DNA from Pulmonary Metastases in the Methylotrophic Yeast Pichia Pastoris KM71H Strain

Mohseni AH, Soleimani M, Majidzadeh-A K, Taghinezhad-S S, Keyvani H.

Asian Pac J Cancer Prev. 2017 Aug 27;18(8):2249-2254.

23.

Clinical Evidence on the Magnitude of Change in Growth Pathway Activity in Relation to Tamoxifen Resistance is Required.

Mansouri S, Farahmand L, Teymourzadeh A, Majidzadeh-A K.

Curr Cancer Drug Targets. 2018;18(7):668-676. doi: 10.2174/1568009617666170808110820.

PMID:
28786348
24.

Estrogen can restore Tamoxifen sensitivity in breast cancer cells amidst the complex network of resistance.

Mansouri S, Farahmand L, Hosseinzade A, Eslami-S Z, Majidzadeh-A K.

Biomed Pharmacother. 2017 Sep;93:1320-1325. doi: 10.1016/j.biopha.2017.07.057. Epub 2017 Jul 23. Review.

PMID:
28747013
25.

Significant Role of MUC1 in Development of Resistance to Currently Existing Anti-cancer Therapeutic Agents.

Farahmand L, Merikhian P, Jalili N, Darvishi B, Majidzadeh-A K.

Curr Cancer Drug Targets. 2018;18(8):737-748. doi: 10.2174/1568009617666170623113520.

PMID:
28669345
26.

NF-κB as the main node of resistance to receptor tyrosine kinase inhibitors in triple-negative breast cancer.

Darvishi B, Farahmand L, Eslami-S Z, Majidzadeh-A K.

Tumour Biol. 2017 Jun;39(6):1010428317706919. doi: 10.1177/1010428317706919. Review.

PMID:
28653902
27.

Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer.

Darvishi B, Farahmand L, Majidzadeh-A K.

Mol Ther Nucleic Acids. 2017 Jun 16;7:164-180. doi: 10.1016/j.omtn.2017.03.007. Epub 2017 Mar 29. Review.

28.

MUC1 induces tamoxifen resistance in estrogen receptor-positive breast cancer.

Merikhian P, Ghadirian R, Farahmand L, Mansouri S, Majidzadeh-A K.

Expert Rev Anticancer Ther. 2017 Jul;17(7):607-613. doi: 10.1080/14737140.2017.1340837. Epub 2017 Jun 21. Review.

PMID:
28597750
29.

ER-α36 Interactions With Cytosolic Molecular Network in Acquired Tamoxifen Resistance.

Teymourzadeh A, Mansouri S, Farahmand L, Hosseinzade A, Majidzadeh-A K.

Clin Breast Cancer. 2017 Oct;17(6):403-407. doi: 10.1016/j.clbc.2017.03.013. Epub 2017 Mar 30. Review.

PMID:
28433540
30.

Wip1: A candidate phosphatase for cancer diagnosis and treatment.

Oghabi Bakhshaiesh T, Majidzadeh-A K, Esmaeili R.

DNA Repair (Amst). 2017 Jun;54:63-66. doi: 10.1016/j.dnarep.2017.03.004. Epub 2017 Mar 20. Review.

PMID:
28385459
31.

Patterns of Cancer Stem Cell Negotiation with Breast Cancer Anti-angiogenic Therapy.

Darvishi B, Farahmand L, Majidzadeh-A K.

Breast J. 2017 Sep;23(5):612-614. doi: 10.1111/tbj.12806. Epub 2017 Mar 30. No abstract available.

PMID:
28370769
32.

Clinical significance of NDRG3 in patients with breast cancer.

Estiar MA, Zare AA, Esmaeili R, Farahmand L, Fazilaty H, Jafari D, Samadi T, Majidzadeh-A K.

Future Oncol. 2017 May;13(11):961-969. doi: 10.2217/fon-2016-0457. Epub 2017 Feb 27.

PMID:
28326836
33.

MED1 may explain the interaction between receptor tyrosine kinases and ERα66 in the complicated network of Tamoxifen resistance.

Mansouri S, Naghavi-Al-Hosseini F, Farahmand L, Majidzadeh-A K.

Eur J Pharmacol. 2017 Jun 5;804:78-81. doi: 10.1016/j.ejphar.2017.03.026. Epub 2017 Mar 16. Review.

PMID:
28322840
34.

Extremely low frequency magnetic field enhances glucose oxidase expression in Pichia pastoris GS115.

Madjid Ansari A, Majidzadeh-A K, Darvishi B, Sanati H, Farahmand L, Norouzian D.

Enzyme Microb Technol. 2017 Mar;98:67-75. doi: 10.1016/j.enzmictec.2016.12.011. Epub 2017 Jan 3.

PMID:
28110666
35.

High expression of CEACAM19, a new member of carcinoembryonic antigen gene family, in patients with breast cancer.

Estiar MA, Esmaeili R, Zare AA, Farahmand L, Fazilaty H, Zekri A, Jafarbeik-Iravani N, Majidzadeh-A K.

Clin Exp Med. 2017 Nov;17(4):547-553. doi: 10.1007/s10238-016-0442-1. Epub 2016 Dec 1.

PMID:
27909883
36.

Blinatumomab provoked fatal heart failure.

Darvishi B, Farahmand L, Jalili N, Majidzadeh-A K.

Int Immunopharmacol. 2016 Dec;41:42-46. doi: 10.1016/j.intimp.2016.10.017. Epub 2016 Oct 28. Review.

PMID:
27816725
37.

Iranian women's attitude toward prophylactic mastectomy for breast cancer.

Majidzadeh-A K, Farahmand L, Zare AA, Esmaeili R, Salehi M, Habibi M.

J Cancer Res Ther. 2016 Apr-Jun;12(2):915-9. doi: 10.4103/0973-1482.171363.

38.

Association of vitamin D receptor gene variants with polycystic ovary syndrome: A case control study.

Mahmoudi T, Majidzadeh-A K, Farahani H, Mirakhorli M, Dabiri R, Nobakht H, Asadi A.

Int J Reprod Biomed (Yazd). 2015 Dec;13(12):793-800.

39.

Effects of short term and long term Extremely Low Frequency Magnetic Field on depressive disorder in mice: Involvement of nitric oxide pathway.

Madjid Ansari A, Farzampour S, Sadr A, Shekarchi B, Majidzadeh-A K.

Life Sci. 2016 Feb 1;146:52-7. doi: 10.1016/j.lfs.2015.12.055. Epub 2016 Jan 5.

PMID:
26764231
40.

AKAP3 correlates with triple negative status and disease free survival in breast cancer.

Esmaeili R, Majidzadeh-A K, Farahmand L, Ghasemi M, Salehi M, Khoshdel AR.

BMC Cancer. 2015 Oct 12;15:681. doi: 10.1186/s12885-015-1668-0.

41.

Gly972Arg variant of insulin receptor substrate 1 gene and colorectal cancer risk in overweight/obese subjects.

Mahmoudi T, Majidzadeh-A K, Karimi K, Farahani H, Dabiri R, Nobakht H, Asadi A, Karimi N, Arkani M, Zali MR.

Int J Biol Markers. 2016 Feb 28;31(1):e68-72. doi: 10.5301/jbm.5000159.

PMID:
26349669
42.

Antitumor effect of conditioned media derived from murine MSCs and 5-aminolevulinic acid (5-ALA) mediated photodynamic therapy in breast cancer in vitro.

Mohammadpour H, Majidzadeh-A K.

Photodiagnosis Photodyn Ther. 2015 Jun;12(2):238-43. doi: 10.1016/j.pdpdt.2015.02.004. Epub 2015 Feb 24.

PMID:
25721458
43.

Effect of Copper Sulfate on Expression of Endogenous L1 Retrotransposons in HepG2 Cells (Hepatocellular Carcinoma).

Karimi A, Majidzadeh-A K, Madjd Z, Akbari A, Habibi L, Akrami SM.

Biol Trace Elem Res. 2015 Jun;165(2):131-4. doi: 10.1007/s12011-015-0256-0. Epub 2015 Feb 8.

PMID:
25663478
44.

An exon variant in insulin receptor gene is associated with susceptibility to colorectal cancer in women.

Mahmoudi T, Majidzadeh-A K, Karimi K, Karimi N, Farahani H, Dabiri R, Nobakht H, Dolatmoradi H, Arkani M, Zali MR.

Tumour Biol. 2015 May;36(5):3709-15. doi: 10.1007/s13277-014-3010-x. Epub 2015 Jan 5.

PMID:
25557790
45.

Design of a novel chimeric tissue plasminogen activator with favorable Vampire bat plasminogen activator properties.

Kazemali M, Majidzadeh-A K, Sardari S, Saadatirad AH, Khalaj V, Zarei N, Barkhordari F, Adeli A, Mahboudi F.

Enzyme Microb Technol. 2014 Dec;67:82-6. doi: 10.1016/j.enzmictec.2014.09.005. Epub 2014 Sep 22.

PMID:
25442953
46.

Plasma proteomics analysis of tamoxifen resistance in breast cancer.

Majidzadeh-A K, Gharechahi J.

Med Oncol. 2013 Dec;30(4):753. doi: 10.1007/s12032-013-0753-y. Epub 2013 Oct 26.

PMID:
24158757
47.

Development and Application of an In-house Line Probe Assay for Hepatitis C Virus Genotyping.

Majidzadeh-A K, Morovvati A, Soleimani M, Langeroudi AG, Merat S, Jabbari H.

Hepat Mon. 2013 Apr 30;13(5):e6767. doi: 10.5812/hepatmon.6767. Print 2013 May.

48.

Sagittal abdominal diameter to triceps skinfold thickness ratio: a novel anthropometric index to predict premature coronary atherosclerosis.

Vasheghani-Farahani A, Majidzadeh-A K, Masoudkabir F, Karbalai S, Koleini M, Aiatollahzade-Esfahani F, Pashang M, Hakki E.

Atherosclerosis. 2013 Apr;227(2):329-33. doi: 10.1016/j.atherosclerosis.2013.01.033. Epub 2013 Feb 8.

PMID:
23466099
49.

Ligation Independent Cloning of Polycistronic, Genetically Modified, HuMAb4D5-8 F (ab') 2, in Bacterial Plasmid.

Farahmand L, Majidzadeh-A K, Sepehrizadeh Z, Mofid MR, Esmaeili R, Yazdi MT.

Avicenna J Med Biotechnol. 2012 Jan;4(1):15-22.

50.

BsmI but not FokI polymorphism of VDR gene is contributed in breast cancer.

Shahbazi S, Alavi S, Majidzadeh-A K, Ghaffarpour M, Soleimani A, Mahdian R.

Med Oncol. 2013 Mar;30(1):393. doi: 10.1007/s12032-012-0393-7. Epub 2013 Jan 1.

PMID:
23277283

Supplemental Content

Loading ...
Support Center